Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05973630
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-07
First Post:
2023-07-24
Brief Title:
ATA-200 Dose-escalation Gene Therapy Trial in Patients with LGMDR5
Sponsor:
Atamyo Therapeutics
Organization:
Atamyo Therapeutics
Organization Data
Organization:
Atamyo Therapeutics
Class:
INDUSTRY
Study ID:
ATA-003-GSAR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Atamyo Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None